Latest International Markets News

Biome Australia has reported record-breaking sales revenue for FY25, driven by strong domestic demand and promising international expansion. The company is on track to deliver its first full-year net profit and meet ambitious growth targets.

Battery Age Minerals has secured its first drilling permit for the Bleiberg Zinc-Germanium Project in Austria, setting the stage for exploration at one of Europe’s richest germanium sources amid tightening global supply.

Anagenics Limited’s licensed brand Bouf Haircare is outperforming expectations with strong early sales and promising royalty returns, signaling robust growth potential for the company’s intellectual property portfolio.

xReality Group has raised $2 million through a discounted share placement to fuel the international expansion of its Operator XR virtual reality training platform, targeting law enforcement and military sectors.

Bailador Technology Investments has updated its portfolio valuations, revealing strong gains in key holdings and a projected gross return of 32.8% for FY25. However, one investment saw a significant decline, tempering overall optimism.

Perenti’s underground mining arm, Barminco, has won a significant three-year contract with Westgold Resources at the Great Fingall project, boosting its Australian mining portfolio and promising steady revenue growth.

Virgin Australia Holdings Limited is set to list on the ASX, raising $685 million through a mix of new and existing shares, showcasing its transformation journey and strategic partnership with Qatar Airways.

Zoono Group Limited has announced a pro rata non-renounceable rights issue aiming to raise approximately $1.78 million at $0.035 per share. The capital raise will support shelf-life extension projects, repay related party debt, and bolster working capital.

Kelsian’s Hotard Coaches has won a $59 million contract to provide workforce transportation for the Venture Global LNG CP2 project in Louisiana, marking a significant expansion in its US operations.

Bioxyne Limited's subsidiary Breathe Life Sciences has achieved key GMP certifications across multiple international markets, paving the way for expanded operations in Europe, the UK, Canada, and Singapore. The company signals strong growth prospects for FY2026, with formal guidance expected in August.

Cann Group Limited has received a $315,552 advance on its expected FY2025 Research and Development Tax Incentive, marking the second tranche of funding to support its ongoing cannabis medicine development.

Bubs Australia has submitted critical clinical trial data to the US FDA, marking a pivotal step toward permanent approval for its infant formulas in the US market.